Genomics Market Size To Hit US$ 98.7 Billion By 2030

The global genomics market size is expected to hit around USD 98.7 billion by 2030 and progressing a CAGR of 16.85% over the forecast period 2022 to 2030.

The on genomics Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1204

Scope of the Report

Report Highlights	Details
Market Size	USD 98.7 Billion by 2030
Growth Rate	CAGR of 16.85% From 2022 to 2030
Base Year	2020
Historic Data	2017 to 2020
Forecast Period	2022 to 2030
Segments Covered	Product and Services, Technology, Application, End-Users
Regional Scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

A recent report provides crucial insights along with application based and forecast information in the Global Genomics Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Genomics market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Genomics market are included as given below:

Genomics Market Key Players

Thermo Fisher Scientific, Inc.
Illumina, Inc.
Oxford Nanopore Technologies
QIAGEN N.V.
BGI
Eurofins Scientific
GE Healthcare
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Hoffmann-La Roche Ltd.
Others

Market Segments

By Product and Services

Consumables
Systems and software
Services Equipment

By Technology

PCR (polymerase chain reaction)
Sequencing
Microarray
Nucleic acid extraction and purification
Other technologies (branched DNA analysis, single-cell genomics analysis, and flow cytometry)

By Application

Drug discovery and development
Diagnostics
Precision medicine
Agriculture and animal research
Other applications

By End-Users

Hospitals & clinics
Research centers and academic & government institutes
Pharmaceutical & biotechnology companies
Other end users

By Regional Outlook

North America
- US.
- Canada
Europe
- UK.
- Germany
- France
Asia Pacific
- China
- India
- Japan
- Southeast Asia
Middle East and Africa
- GCC
- North Africa
- South Africa
- Rest of MEA

Report Objectives

To define, describe, and forecast the global genomics market based on product, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the genomics market

Table of Content

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Genomics Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Genomics Market

5.1. Covid-19: Genomics Industry Impact
5.2. Genomics Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Genomics Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Genomics Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Genomics Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Driver 1
6.1.1.2. Driver 2
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2

Chapter 7. Global Genomics Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Genomics Market Revenue by Market Players (2017-2021)
7.1.1.2. Genomics Market Revenue Market Share by Market Players (2017-2021)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product Type Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Genomics Market, By Product Type

8.1. Genomics Market, by Component, 2018-2030
8.1.1. Consumables
8.1.1.1. Market Revenue and Forecast (2018-2030)
8.1.2. Systems and software
8.1.2.1. Market Revenue and Forecast (2018-2030)
8.1.3. Services Equipment
8.1.3.1. Market Revenue and Forecast (2018-2030)

Chapter 9. Global Genomics Market, By Application

9.1. Genomics Market, by Application, 2018-2030
9.1.1. Sequencing
9.1.1.1. Market Revenue and Forecast (2018-2030)
9.1.2. Microarray
9.1.2.1. Market Revenue and Forecast (2018-2030)
9.1.3. PCR (polymerase chain reaction)
9.1.3.1. Market Revenue and Forecast (2018-2030)
9.1.4. Nucleic acid extraction and purification
9.1.4.1. Market Revenue and Forecast (2018-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2018-2030)

Chapter 10. Global Genomics Market, By End-user

10.1. Genomics Market, by End-user, 2018-2030
10.1.1. Diagnostics
10.1.1.1. Market Revenue and Forecast (2018-2030)
10.1.2. Drug discovery and development
10.1.2.1. Market Revenue and Forecast (2018-2030)
10.1.3. Precision medicine
10.1.3.1. Market Revenue and Forecast (2018-2030)
10.1.4. Agriculture and animal research
10.1.5. Other applications

Chapter 11. Global GenomicsMarket, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product Type(2018-2030)
11.1.2. Market Revenue Forecast by Application (2018-2030)
11.1.3. Market Revenue Forecast by End-user (2018-2030)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2018-2030)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2018-2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Product Type(2018-2030)
11.2.2. Market Revenue Forecast by Application (2018-2030)
11.2.3. Market Revenue Forecast by End-user (2018-2030)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2018-2030)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2018-2030)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2018-2030)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2018-2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product Type(2018-2030)
11.3.2. Market Revenue Forecast by Application (2018-2030)
11.3.3. Market Revenue Forecast by End-user (2018-2030)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2018-2030)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2018-2030)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2018-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2018-2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product Type(2018-2030)
11.4.2. Market Revenue Forecast by Application (2018-2030)
11.4.3. Market Revenue Forecast by End-user (2018-2030)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2018-2030)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2018-2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product Type(2018-2030)
11.5.2. Market Revenue Forecast by Application (2018-2030)
11.5.3. Market Revenue Forecast by End-user (2018-2030)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2018-2030)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2018-2030)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2018-2030)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2018-2030)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin (2017-2021)
12.1.4. Recent Developments and Strategies
12.2. Illumina, Inc.
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin (2017-2021)
12.2.4. Recent Developments and Strategies
12.3. Oxford Nanopore Technologies
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin (2017-2021)
12.3.4. Recent Developments and Strategies
12.4. QIAGEN N.V.
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin (2017-2021)
12.4.4. Recent Developments and Strategies
12.5. BGI
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin (2017-2021)
12.5.4. Recent Developments and Strategies
12.6. Eurofins Scientific
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin (2017-2021)
12.6.4. Recent Developments and Strategies
12.7. GE Healthcare
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin (2017-2021)
12.7.4. Recent Developments and Strategies
12.8. Agilent Technologies, Inc.
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin (2017-2021)
12.8.4. Recent Developments and Strategies
12.9. Bio-Rad Laboratories, Inc.
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin (2017-2021)
12.9.4. Recent Developments and Strategies
12.10. F. Hoffmann-La Roche Ltd.
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin (2017-2021)
12.10.4. Recent Developments and Strategies